Concepedia
Statistics
Publications
8
Citations
738
H-Index
Active since
2011
Affiliations
Weizmann Institute of Science(Current)
Integrated DNA Technologies (United States)
Hebrew University of Jerusalem
Amitai D. Mandelbaum is an author at Weizmann Institute of Science specializing in medicine, gene expression, and cell signaling.
Top concepts
MedicineCell BiologyCell SignalingNon-coding RnaGene ExpressionNatural SciencesGene RegulationSystems BiologyDevelopmental BiologyEpigenetic Regulation
Publications per year
2011–2019
miRNAs control insulin content in pancreatic β‐cells via downregulation of transcriptional repressors
Tal Melkman-Zehavi, Roni Oren, Sharon Kredo‐Russo et al. · The EMBO Journal · 2011 · 281 citations · Full text
Development and characterization of a novel drug nanocarrier for oral delivery, based on self-assembled β-casein micelles
Michal Bachar, Amitai D. Mandelbaum, Irina Portnaya et al. · Journal of Controlled Release · 2012 · 145 citations
Nanoparticles, Nanomedicine, Engineering +10
Pancreas-enriched miRNA refines endocrine cell differentiation
Sharon Kredo‐Russo, Amitai D. Mandelbaum, A. T. Ness et al. · Development · 2012 · 108 citations
Endocrine Cell Differentiation, Epigenetics, Transcriptional Regulation +18
Dysregulation of Dicer1 in Beta Cells Impairs Islet Architecture and Glucose Metabolism
Amitai D. Mandelbaum, Tal Melkman-Zehavi, Roni Oren et al. · Experimental Diabetes Research · 2012 · 60 citations · Full text
Mirnas Activity, Metabolic Remodeling, Insulin Signaling +16
Human genetics and neuropathology suggest a link between miR-218 and amyotrophic lateral sclerosis pathophysiology
Irit Reichenstein, Chen Eitan, Sandra Díaz-García et al. · Science Translational Medicine · 2019 · 59 citations · Full text
1–5 of 8